Charles Schwab Investment Management Inc Sqz Biotechnologies CO Transaction History

Charles Schwab Investment Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.77 - $5.0 $168,119 - $303,465	-60,693 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.01 - $10.42 $16,825 - $43,722	4,196 Added 7.43%	60,693 $292,000
Q4 2021 Feb 11, 2022	BUY	$8.93 - $14.85 $2,830 - $4,707	317 Added 0.56%	56,497 $505,000
Q3 2021 Nov 16, 2021	SELL	$11.46 - $15.77 $312,468 - $429,984	-27,266 Reduced 32.68%	56,180 $811,000
Q2 2021 Aug 16, 2021	BUY	$11.32 - $14.45 $428,258 - $546,672	37,832 Added 82.94%	83,446 $1.21 Million
Q1 2021 May 17, 2021	BUY	$12.07 - $29.9 $248,786 - $616,298	20,612 Added 82.44%	45,614 $624,000
Q4 2020 Feb 16, 2021	BUY	$13.25 - $34.58 $331,276 - $864,569	25,002 New	25,002 $725,000

1.47M

Ticker SQZ
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,248,600
Market Cap $1.46M
Description
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.